Developer docs
API playgroundTry for free, no card

Search company profiles

ThreeWire

Full company profile

uuid000d5k5

Namestring
ThreeWire
Websiteurl
threewire.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

ThreeWire is a US-based, privately held clinical trial services firm founded in 1999 and headquartered in Eden Prairie, Minnesota. Per its firmographic description, the company provides customized clinical trial participant recruitment, enrollment, and retention services to pharmaceutical, biotech, and medical device industry sponsors. The company operates with 11-50 employees and has maintained continuous operations for over 25 years, indicating a niche specialist positioning within the clinical research services value chain.

The input data provides no documented proprietary technology platform, product portfolio, or technical architecture tied to ThreeWire itself. Several source blocks reference WCG Clinical's ClinSphere platform and Total Enrollment technology, but the source material explicitly notes that these pertain to WCG Clinical rather than ThreeWire, and no integration, licensing, or commercial relationship between ThreeWire and WCG is confirmed in the data. The company's revenue model, pricing structure, customer segment mix, and go-to-market approach are similarly undocumented.

ThreeWire's disclosed leadership is limited to a single named executive, James E. Claseman, identified as Chief Financial Officer. No funding history, M&A activity, partnerships directly involving ThreeWire, certifications, geographic footprint beyond the Eden Prairie headquarters, or operating metrics are present in the source data. As a result, this analysis is constrained to firmographic-level inference, and any deeper claims regarding scale, moat depth, or strategic direction would exceed what the evidence supports.

Short descriptiontext

ThreeWire is a privately held, Eden Prairie, Minnesota-based clinical trial services firm, founded in 1999, that provides customized patient recruitment, enrollment, and retention services to pharmaceutical, biotech, and medical device sponsors.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersEden Prairie, United States
HQ citystring
Eden Prairie
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial recruitment, patient enrollment services, clinical trial retention, pharmaceutical research services, biotech clinical research
Industry2 codes
1Patient Recruitment, Site Feasibility & Trial Enablement CROs
CodeHLAGAAAIPrimaryYes
2Site & Investigator Platforms (Site Payments, Feasibility, Activation)
CodeHLACAOAJPrimaryNo
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Recruitment & Retention Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ThreeWire provides customized clinical trial recruitment, enrollment, and retention services for the pharmaceutical, biotech, and medical device industries. The firm supports sponsors and CROs with participant identification, engagement, documentation, and site outreach to help studies meet enrollment targets on time.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Clinical Trial Recruitment Services
Partnership5 partners
1Psyence Biomed
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Psyence Biomed partnered with Australian Clinical Trial Network for Phase IIb trials. This is noted as a notable recent strategic alliance within the SMO sector.

2Australian Clinical Trial Network
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Partnered with Psyence Biomed for Phase IIb trials. This is noted as a notable recent strategic alliance within the SMO sector.

3Neutra Corporation
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Neutra Corporation acquired Mercury Clinical Research. This is noted as a notable recent strategic alliance within the SMO sector.

4Mercury Clinical Research
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Mercury Clinical Research was acquired by Neutra Corporation. This is noted as a notable recent strategic alliance within the SMO sector.

5I'rom Group
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Tokyo-based I'rom Group is subject to a planned acquisition by Blackstone. This is noted as a notable recent strategic alliance within the SMO sector.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
1Syneos Health
TypeBroad incumbent
Description

Full-service biopharmaceutical solutions CRO offering integrated clinical development and commercialization services, including patient recruitment; competes with ThreeWire for mid- and large-sponsor programs.

2Antidote Technologies
TypeEmerging player
Description

Digital patient-recruitment platform that matches patients to clinical trials via partnerships with patient communities and sponsors; an emerging technology-enabled competitor to ThreeWire's recruitment specialty.

3PPD (Thermo Fisher Scientific)
TypeBroad incumbent
Description

Large global CRO offering integrated clinical development services including patient recruitment and retention; competes with ThreeWire as part of broader outsourced development engagements.

4Medpace
TypeDirect peer
Description

Mid-sized, therapeutically focused CRO with strong site-management and enrollment capabilities; competes head-to-head with ThreeWire on Phase II/III recruitment for specialty indications.

5Charles River Laboratories
TypeBroad incumbent
Description

Large CRO and preclinical services provider with an established clinical recruitment and site-services function; competes with ThreeWire for biotech and medical device sponsor recruitment mandates.

6IQVIA
TypeBroad incumbent
Description

Global full-service CRO and life-sciences data provider that operates dedicated patient recruitment and site enablement functions; competes with ThreeWire on large multi-protocol recruitment mandates.

7Worldwide Clinical Trials
TypeDirect peer
Description

Mid-tier global CRO with specialized patient recruitment and feasibility services across complex therapeutic areas; directly comparable to ThreeWire in size, scope, and sponsor base.

8Clinerion
TypeEmerging player
Description

Health-data and patient-recruitment technology company that uses hospital network data to accelerate trial enrollment; an emerging technology-enabled alternative to traditional recruitment firms like ThreeWire.

9Clinical Trial Media
TypeEmerging player
Description

Specialized patient recruitment and retention firm using digital outreach and patient-engagement tactics; a closer-scale direct competitor to ThreeWire on recruitment-only engagements.

10WCG (WIRB-Copernicus Group)
TypeDirect peer
Description

Largest US-based clinical trial services provider with a dedicated recruitment & retention solution and proprietary ClinSphere/Total Enrollment platform; directly overlaps ThreeWire's patient recruitment, enrollment, and retention services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ThreeWire

Clinical Trial Recruitment & Retention Servicesthreewire.com

ThreeWire is a privately held, Eden Prairie, Minnesota-based clinical trial services firm, founded in 1999, that provides customized patient recruitment, enrollment, and retention services to pharmaceutical, biotech, and medical device sponsors.

What ThreeWire does

ThreeWire is a US-based, privately held clinical trial services firm founded in 1999 and headquartered in Eden Prairie, Minnesota. Per its firmographic description, the company provides customized clinical trial participant recruitment, enrollment, and retention services to pharmaceutical, biotech, and medical device industry sponsors. The company operates with 11-50 employees and has maintained continuous operations for over 25 years, indicating a niche specialist positioning within the clinical research services value chain.

The input data provides no documented proprietary technology platform, product portfolio, or technical architecture tied to ThreeWire itself. Several source blocks reference WCG Clinical's ClinSphere platform and Total Enrollment technology, but the source material explicitly notes that these pertain to WCG Clinical rather than ThreeWire, and no integration, licensing, or commercial relationship between ThreeWire and WCG is confirmed in the data. The company's revenue model, pricing structure, customer segment mix, and go-to-market approach are similarly undocumented.

ThreeWire's disclosed leadership is limited to a single named executive, James E. Claseman, identified as Chief Financial Officer. No funding history, M&A activity, partnerships directly involving ThreeWire, certifications, geographic footprint beyond the Eden Prairie headquarters, or operating metrics are present in the source data. As a result, this analysis is constrained to firmographic-level inference, and any deeper claims regarding scale, moat depth, or strategic direction would exceed what the evidence supports.

ThreeWire firmographics

Firmographics
Name
ThreeWire
Website
https://threewire.com
Company type
Private
Founded year
1999
Headcount range
101–250 employees
Short description
ThreeWire is a privately held, Eden Prairie, Minnesota-based clinical trial services firm, founded in 1999, that provides customized patient recruitment, enrollment, and retention services to pharmaceutical, biotech, and medical device sponsors.
Ownership category
akta.pro rank

ThreeWire industry classification

Industry
Product category
Clinical Trial Recruitment & Retention Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
akta.pro secondary industry
Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)

Keywords

  • Clinical trial recruitment
  • Patient enrollment services
  • Clinical trial retention
  • Pharmaceutical research services
  • Biotech clinical research

Where ThreeWire is headquartered

Location

Headquarters

HQ city
Eden Prairie
HQ country
United States
HQ region
North America

Markets served

ThreeWire business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

ThreeWire product offering

Product offering

Core offering

ThreeWire provides customized clinical trial recruitment, enrollment, and retention services for the pharmaceutical, biotech, and medical device industries. The firm supports sponsors and CROs with participant identification, engagement, documentation, and site outreach to help studies meet enrollment targets on time.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Recruitment Services

Companies that use ThreeWire

Customer profile

Ideal customer profiles1 record

ThreeWire technology and API

Technology

Technology focussed No

API detail

API docs
API detail

Core technology

AI maturity

App detail

ThreeWire partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered notable.

  • Psyence BiomednotableStrategic or Co-development PartnerPsyence Biomed partnered with Australian Clinical Trial Network for Phase IIb trials. This is noted as a notable recent strategic alliance within the SMO sector.
  • Australian Clinical Trial NetworknotableStrategic or Co-development PartnerPartnered with Psyence Biomed for Phase IIb trials. This is noted as a notable recent strategic alliance within the SMO sector.
  • Neutra CorporationnotableStrategic or Co-development PartnerNeutra Corporation acquired Mercury Clinical Research. This is noted as a notable recent strategic alliance within the SMO sector.
  • Mercury Clinical ResearchnotableStrategic or Co-development PartnerMercury Clinical Research was acquired by Neutra Corporation. This is noted as a notable recent strategic alliance within the SMO sector.
  • I'rom GroupnotableStrategic or Co-development PartnerTokyo-based I'rom Group is subject to a planned acquisition by Blackstone. This is noted as a notable recent strategic alliance within the SMO sector.

Recent moves1 record

ThreeWire competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health: Full-service biopharmaceutical solutions CRO offering integrated clinical development and commercialization services, including patient recruitment; competes with ThreeWire for mid- and large-sponsor programs.
  • PPD (Thermo Fisher Scientific): Large global CRO offering integrated clinical development services including patient recruitment and retention; competes with ThreeWire as part of broader outsourced development engagements.
  • Charles River Laboratories: Large CRO and preclinical services provider with an established clinical recruitment and site-services function; competes with ThreeWire for biotech and medical device sponsor recruitment mandates.
  • IQVIA: Global full-service CRO and life-sciences data provider that operates dedicated patient recruitment and site enablement functions; competes with ThreeWire on large multi-protocol recruitment mandates.

Emerging players

  • Antidote Technologies: Digital patient-recruitment platform that matches patients to clinical trials via partnerships with patient communities and sponsors; an emerging technology-enabled competitor to ThreeWire's recruitment specialty.
  • Clinerion: Health-data and patient-recruitment technology company that uses hospital network data to accelerate trial enrollment; an emerging technology-enabled alternative to traditional recruitment firms like ThreeWire.
  • Clinical Trial Media: Specialized patient recruitment and retention firm using digital outreach and patient-engagement tactics; a closer-scale direct competitor to ThreeWire on recruitment-only engagements.

Direct peers

  • Medpace: Mid-sized, therapeutically focused CRO with strong site-management and enrollment capabilities; competes head-to-head with ThreeWire on Phase II/III recruitment for specialty indications.
  • Worldwide Clinical Trials: Mid-tier global CRO with specialized patient recruitment and feasibility services across complex therapeutic areas; directly comparable to ThreeWire in size, scope, and sponsor base.
  • WCG (WIRB-Copernicus Group): Largest US-based clinical trial services provider with a dedicated recruitment & retention solution and proprietary ClinSphere/Total Enrollment platform; directly overlaps ThreeWire's patient recruitment, enrollment, and retention services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

ThreeWire social profiles

Digital presence

ThreeWire financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ThreeWire leadership team

Management profile

Number of profiles

Profiles1 record

ThreeWire funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ThreeWire M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ThreeWire

What does ThreeWire do?

ThreeWire provides customized clinical trial recruitment, enrollment, and retention services for the pharmaceutical, biotech, and medical device industries. The firm supports sponsors and CROs with participant identification, engagement, documentation, and site outreach to help studies meet enrollment targets on time.

When was ThreeWire founded?

ThreeWire was founded in 1999. It employs 101 to 250 people.

Where is ThreeWire based?

ThreeWire is headquartered in Eden Prairie, United States, in the North America region.

Who are ThreeWire's main competitors?

Broad incumbents on record are Syneos Health, PPD (Thermo Fisher Scientific), Charles River Laboratories and IQVIA. Emerging players are Antidote Technologies, Clinerion and Clinical Trial Media. Direct peers are Medpace, Worldwide Clinical Trials and WCG (WIRB-Copernicus Group).

What industry is ThreeWire in?

ThreeWire's product category is Clinical Trial Recruitment & Retention Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSkupina WIRB-Copernicus Group koupila společnost ThreeWire a rozšiřuje služby pro zlepšení přijímání a přihlašování účastníků do klinických studií a jejich udrženíWIRB-Copernicus Group (WCG) acquired ThreeWire, a company specializing in patient recruitment and retention for clinical trials. This acquisition expands WCG's service portfolio to help pharmaceutical sponsors and research organizations improve enrollment efficiency and reduce costs in increasingly complex clinical studies. ThreeWire will continue to operate as an independent entity within the WCG group.PR NewswireLe WIRB-Copernicus Group acquiert ThreeWire, élargit ses services visant à améliorer le recrutement, l'inscription et la rétention dans le cadre des études cliniquesWIRB-Copernicus Group (WCG) has acquired ThreeWire, a global patient recruitment, enrollment, and retention firm serving pharmaceutical companies, medical device firms, and clinical research organizations for clinical trials. ThreeWire has evaluated more than 2 million patients across more than 25 countries using a systematic, patient-focused approach that helps sponsors achieve recruitment goals and can save millions of dollars. ThreeWire will continue operating as an independent organization while gaining access to WCG's capital, clinical and regulatory expertise, and corporate support for expansion.PR NewswireWIRB-Copernicus Group dokonuje nabycia ThreeWire i poszerza zakres usług w celu poprawy rekrutacji, rejestracji i retencjiWIRB-Copernicus Group (WCG), a leading provider of clinical trial solutions, has completed the acquisition of ThreeWire, a global patient recruitment, enrollment, and retention company. ThreeWire has screened over 2 million patients across 25 countries and employs more than 300 research staff called Enrollment Assistants who work directly in clinical trial sites. The acquisition expands WCG's service portfolio, enabling faster patient recruitment and enrollment while reducing the workload on clinical researchers and saving sponsors millions of dollars in development costs.PR NewswireSpoločnosť WIRB-Copernicus Group získava firmu ThreeWire a rozširuje služby s cieľom skvalitniť nábor, registráciu a účasť v klinickom skúšaníWIRB-Copernicus Group (WCG) acquired ThreeWire in May 2017 to expand its patient recruitment, registration, and clinical trial participation services. ThreeWire brings a database of 2 million patients across more than 25 countries and a team of over 300 enrollment specialists, which WCG says will help sponsors accelerate patient enrollment and reduce costs. ThreeWire will continue operating as an independent organization under WCG's ownership, with financial terms of the transaction undisclosed.PR NewswireWIRB-Copernicus Group erwirbt ThreeWire, erweitert Dienste zur Verbesserung der Anwerbung, Aufnahme und Bindung in klinischen StudienWIRB-Copernicus Group (WCG) has acquired ThreeWire, a global patient recruitment and enrollment company serving biopharmaceutical companies, medical device companies, and clinical research organizations. ThreeWire has screened over 2 million patients across more than 25 countries and employs over 300 clinical research professionals, offering services that can accelerate patient recruitment and save clients millions of dollars. ThreeWire will continue operating as an independent company within the WCG family, with access to WCG's capital, clinical and regulatory expertise, and operational support.PR NewswireWIRB-Copernicus Group приобретает ThreeWire, расширяя портфель сервисов для оптимизации процессов подбора субъектов и удержания пациентов в клиническом исследованииWIRB-Copernicus Group (WCG), a leading provider of clinical research solutions headquartered in Princeton, New Jersey, has acquired ThreeWire, an international firm specializing in patient recruitment, enrollment, and retention services for clinical trials. ThreeWire has screened over 2 million patients across more than 25 countries using a disciplined, patient-centric approach. The acquisition enables WCG to expand its service portfolio for identifying candidates and connecting them with clinical sites, potentially saving sponsors millions of dollars while ThreeWire continues to operate as an independent organization within the WCG group.PR NewswireAdquisición de ThreeWire por parte de WIRB-Copernicus GroupWIRB-Copernicus Group (WCG) announced on May 2, 2017 the acquisition of ThreeWire, a global patient recruitment and retention company for clinical trials. ThreeWire utilizes a patient-centered systematic approach to help pharmaceutical companies, medical device companies, and clinical research organizations achieve enrollment and retention goals, having examined over 200 million patients across more than 25 countries. ThreeWire will continue operating as an independent organization while receiving capital, regulatory expertise, and business support from WCG to facilitate its continued expansion.